NAFLD prevalence: 69.5% in diabetics    NAFLD significantly linked to higher coronary, cerebrovascular, and peripheral CVD (P < 0.001). Association independent of metabolic syndrome (OR 1.84). 86% of NAFLD patients had normal ALT, highlighting limits of liver enzyme screening. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.